On this episode of Alloutcoach, host Tim Mikhelashvili, CEO, Amedea Pharma convenes a panel you rarely hear in one room: a policy-minded biohacker and investor (John Hemming, CEO of Cirrostratus, Biohacking Team Leader), a strategy and operations leader who reshapes patient journeys (Bart Zoni, Senior Vice President, Marketing, Woven Health Collective), and an early-stage investor focused on medical technologies (Chris Piedmonte, Managing Director, Neoterra Capital) as well as a senior pharma thought leader in Medical Affairs and Health Economics, Janelle Hardisty. Their catalyst? Fresh takeaways from the 2025 Financial Times US Pharma summit — and an honest look at what’s truly accelerating innovation, what’s stalling it, and where capital and talent should go next.

00:00:00 Cold Open - Episode Highlights: AI accuracy and access
00:03:43 Host Intro and Why This Episode
00:04:41 Guest Intros
00:08:06 State of Innovation - Tailwinds and Headwinds
00:12:41 What’s Really Accelerating Innovation?
00:19:27 Drug Discovery - Reducing the 90% Failure Rate
00:22:01 Clinical Trials - Modernize or Stall
00:25:11 Access, PBMs, and Direct-to-Patient
00:27:03 Longevity and Prevention - Can We Measure It?
00:36:52 Data Culture Maturity and Pilot Fatigue
00:45:52 Training the Future Workforce
00:51:09 Investing - Where Should Capital Flow?
00:57:08 Regulatory Reality and Time-to-Access
00:59:27 Closing and Invite to Medical Innovation Olympics